Chengdu Kanghua Biological Products - Asset Resilience Ratio

Latest as of March 2024: 1.19%

Chengdu Kanghua Biological Products (300841) has an Asset Resilience Ratio of 1.19% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Chengdu Kanghua Biological Products to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥50.00 Million

≈ $7.32 Million USD Cash + Short-term Investments

Total Assets

CN¥4.20 Billion

≈ $614.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2020)

This chart shows how Chengdu Kanghua Biological Products's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Chengdu Kanghua Biological Products.

Liquid Assets Composition Over Time

This chart breaks down Chengdu Kanghua Biological Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Chengdu Kanghua Biological Products total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥50.00 Million	1.19%
Total Liquid Assets	CN¥50.00 Million	1.19%

Asset Resilience Insights

Limited Liquidity: Chengdu Kanghua Biological Products maintains only 1.19% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chengdu Kanghua Biological Products Industry Peers by Asset Resilience Ratio

Compare Chengdu Kanghua Biological Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
ALK-Abelló A/S CO:ALK-B	Biotechnology	0.98%
Mirum Pharmaceuticals Inc NASDAQ:MIRM	Biotechnology	6.89%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Beijing Konruns Pharmaceutical Co Ltd SHG:603590	Biotechnology	10.55%

Annual Asset Resilience Ratio for Chengdu Kanghua Biological Products (2020–2020)

The table below shows the annual Asset Resilience Ratio data for Chengdu Kanghua Biological Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	8.38%	CN¥180.00 Million ≈ $26.34 Million	CN¥2.15 Billion ≈ $314.27 Million	--

pp = percentage points

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$955.52 Million

CN¥6.53 Billion CNY

Market Cap Rank

#9134 Global

#2251 in China

Share Price

CN¥50.25

Change (1 day)

+1.41%

52-Week Range

CN¥42.86 - CN¥84.21

All Time High

CN¥399.08